Acute Cerebellar Ataxia Induced by Nivolumab-Reference-Cited by-同舟云学术

Acute Cerebellar Ataxia Induced by Nivolumab

Published:2017 Issue:24 Volume:56 Page:3357-3359
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kawamura Reina¹,Nagata Eiichiro¹,Mukai Masako¹,Ohnuki Yoichi¹,Matsuzaki Tomohiko²,Ohiwa Kana²,Nakagawa Tomoki²,Kohno Mitsutomo²,Masuda Ryota²,Iwazaki Masayuki²,Takizawa Shunya¹

Affiliation:

1. Department of Neurology, Tokai University School of Medicine, Japan

2. Department of Thoracic Surgery, Tokai University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/24/56_8895-17/_pdf

Reference9 articles.

1. 1. Zimmer L, Goldinger SM, Hofmann L, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 60: 210-225, 2016.

2. 2. Hottinger AF. Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 29: 806-812, 2016.

3. 3. Kimura T, Fukushima S, Miyashita A, et al. Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107: 1055-1058, 2016.

4. 4. Williams TJ, Benavides DR, Patrice KA, et al. Association of autoimmune encephalitis with combuned immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 73: 928-933, 2016.

5. 5. Sawaishi Y, Takada G. Acute cerebellitis. Cerebellum 1: 223-228, 2002.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia;The Cerebellum;2024-08-17

2. Update on Neuro-ophthalmic Manifestations of Immune Checkpoint Inhibitors;Current Neurology and Neuroscience Reports;2024-03-18

3. A Case of Anti-Ma2 Encephalitis Presenting with Pendular Torsional Nystagmus;The Cerebellum;2023-10-18

4. Immune Checkpoint Inhibitor‐Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism;Movement Disorders Clinical Practice;2023-08

5. Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management;Expert Review of Clinical Pharmacology;2023-05-04